CD44 is not an adhesive receptor for osteopontin

Journal of Cellular Biochemistry

Volumn 73, Issue 1, 1999, Pages 20-30

  Smith, Laura L ^a   Greenfield, Brad W ^b   Aruffo, Alejandro ^b   Giachelli, Cecilia M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Adhesion; CD44 splice variants; CD44 hlg; Integrin; RGD

Indexed keywords

GLYCOPROTEIN; HERMES ANTIGEN; HYALURONIC ACID; HYBRID PROTEIN; IMMUNOGLOBULIN; INTEGRIN; INTEGRIN RECEPTOR; OSTEOPONTIN; THROMBIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; SMOOTH MUSCLE FIBER;

ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; CATIONS, DIVALENT; CELL ADHESION; COS CELLS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULINS; LIGANDS; OSTEOPONTIN; PROTEIN ISOFORMS; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; SIALOGLYCOPROTEINS;

ANIMALIA;

EID: 0033120471     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990401)73:1<20::AID-JCB3>3.0.CO;2-3     Document Type: Article

References (69)

1. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313.
2. Bartolazzi A, Jackson D, Bennett K, Aruffo A, Dickinson R, Shields J, Whittle N, Stamenkovic I. 1995. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 108:1723-1733.
3. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I. 1996. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132: 1199-1208.
4. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A. 1995a. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687-698.
5. Bennett KL, Modrell B, Greenfield B, Bartolazzi A, Stamenkovic I, Peach R, Jackson DG, Spring F, Aruffo A. 1995b. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 131:1623-1633.
6. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. 1993. Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22:147-159.
7. Butler WT, Ridall AL, McKee MD. 1996. Osteopontin. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego, CA: Academic Press. p 167-181.
8. Cooper DL, Dougherty GJ. 1995. To metastasize or not? Selection of CD44 splice sites. Nat Med 1:635-7.
9. Culty M, Miyake K, Kincade PW, Sikorski E, Butcher EC, Underhill C, Silorski ESS. 1990. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513]. J Cell Biol 111: 2765-2774.
10. D'Errico JA, Sauk JJ, Prince CW, Somerman MJ. 1995. Osteopontin adhesion receptors on gingival fibroblasts. J Periodontal Res 30:34-41.
11. Denhardt DT, Chambers AF. 1994. Overcoming obstacles to metastasis - defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 56:48-51.
12. Denhardt DT, Guo X. 1993. Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482.
13. Denhardt DT, Lopez CA, Rollo EE, Hwang SM, An XR, Walther SE. 1995 Osteopontin-induced modifications of cellular functions. Ann NY Acad Sci 760:127-142.
14. Ek Rylander B, Flores M, Wendel M, Heinegard D, Andersson G. 1994. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269:14853-14856.
15. Flores ME, Heinegard D, Reinholt FP, Andersson G. 1996. Bone sialoprotein coated on glass and plastic surfaces is recognized by different beta 3 integrins. Exp Cell Res 227:40-46.
16. Freed E, Gailit J, van der Geer P, Ruoslahti E, Hunter T. 1989. A novel integrin beta subunit is associated with the vitronectin receptor alpha subunit (alpha v) in a human osteosarcoma cell line and is a substrate for protein kinase C. EMBO J 8:2955-2965.
17. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM.1993. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 92:1686-1696.
18. Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M. 1995a. Osteopontin expression in cardiovascular diseases. Ann NY Acad Sci 760:109-126.
19. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ. 1994. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524.
20. Giachelli CM, Scatena M, Wada T. 1997. Osteopontin: Potential roles in vascular function and dystrophic calcification. J Bone Miner Metab 15:179-183.
21. Giachelli CM, Schwartz SM, Liaw L. 1995b. Molecular and cellular biology of osteopontin: Potential role in cardiovascular disease. Trends Cardiovas med 5:88-95.
22. Griffioen AW, Coenen MJ, Damen CA, Hellwig SM, van Weering DH, Vooys W, Blijham GH, Groenewegen G. 1997. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood 90:1150-1159.
23. Gunthert U. 1996. CD44 in malignant disorders. Curr Top Microbiol Immunol 213:271-285.
24. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24.
25. Haynes BF, Telen MJ, Hale LP, Denning SM. 1989. CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423-428.
26. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunthert U. 1991. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292-5297.
27. Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW. 1995. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem 270:26232-26238.
28. Hunter GK, Kyle CL, Goldberg HA. 1994. Modulation of crystal formation by bone phosphoproteins: Structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 300:723-728.
29. Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT. 1994. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269:711-715.
30. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N. 1995. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673-685.
31. Jain M, He Q, Lee WS, Kashiki S, Foster LC, Tsai JC, Lee ME, Haber E. 1996. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest 97:596-603.
32. Jalkanen S, Jalkanen M. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817-825.
33. Jalkanen ST, Bargatze RF, Herron LR, Butcher EC. 1986. A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16:1195-202.
34. Kasugai S, Todescan R, Jr., Nagata T, Yao KL, Butler WT, Sodek J. 1991. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: Inductive effects of dexamethasone on the osteoblastic phenotype. J Cell Physiol 147:111-120.
35. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 182:419-429.
36. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST. 1993. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897-904.
37. Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J. 1994. H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54:6275-6281.
38. Lesley J, English N, Perschl A, Gregoroff J, Hyman R. 1995. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182:431-437.
39. Lesley J, Hyman R, Kincade PW. 1993. CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271-335.
40. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. 1994. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 74:214-224.
41. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BLM. 1998. Altered wound healing in mice lacking a functional osteopontin gene. J Clin Invest 101:1468-1478.
42. Liaw L, Lindner V, Schwartz SM, Chambers AF, Giachelli CM. 1995a. Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 77:665-672.
43. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. 1995b. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 95:713-724.
44. Matsumura Y, Tarin D. 1992. Significance of CD44 gene products for cancer diagnosis and disease evaluation [see comments]. Lancet 340:1053-1058.
45. Miyake K, Underhill CB, Lesley J, Kincade PW. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:69-75.
46. Murry CE, Giachelli CM, Schwartz SM, Vracko R. 1994. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145:1450-1462.
47. Nasu K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. 1995. Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells. Biochem J 307: 257-265.
48. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM. 1995. Osteopontin is expressed in human aortic valvular lesions. Circulation 92:2163-2168.
49. Oates AJ, Barraclough R, Rudland PS. 1997. The role of osteopontin in tumorigenesis and metastasis. Invas Metast 17:1-15.
50. Patarca R, Saavedra RA, Cantor H. 1993. Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 13:225-246.
51. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122:257-264.
52. Russo C, Callegaro L, Lanza E, Ferrone S. 1983. Re.: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Meth 65:269-271.
53. Saavedra RA. 1994. The roles of autophosphorylation and phosphorylation in the life of osteopontin. BioEssays 16:913-918.
54. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 89:12160-12164.
55. Shanmugam V, Chackalaparampil I, Kundu GC, Mukherjee AB, Mukherjee BB. 1997. Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells. Biochemistry 36:5729-5738.
56. Singh K, DeVouge MW, Mukherjee BB. 1990. Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J Biol Chem 265:18696-18701.
57. Smith LL, Cheung HK, Ling LE, Chen J, Sheppard D, Pytela R, Giachelli CM. 1996. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. J Biol Chem 271:28485-28491.
58. Sorensen ES, Petersen TE. 1994. Identification of two phosphorylation motifs in bovine osteopontin. Biochem Biophys Res Commun 198:200-205.
59. Sorensen ES, Petersen TE. 1995. Phosphorylation, glycosylation, and transglutaminase sites in bovine osteopontin. Ann NY Acad Sci 760:363-366.
60. Stamenkovic I, Amiot M, Pesando JM, Seed B. 1989. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057-1062.
61. Taher TE, Smit L, Griffioen AW, Schilder Tol EJ, Borst J, Pals ST. 1996. Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J Biol Chem 271:2863-2867.
62. Tanabe KK, Ellis LM, Saya H. 1993. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341:725-726.
63. Terpe HJ, Koopmann R, Imhof BA, Gunthert U. 1994. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 174:89-100.
64. Tyrrell DJ, Ishihara M, Rao N, Horne A, Kiefer MC, Stauber GB, Lam LH, Stack RJ. 1993. Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor. J Biol Chem 268:4684-4689.
65. Weber GF, Ashkar S, Glimcher MJ, Cantor H. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512.
66. Xuan JW, Hota C, Chambers AF. 1994. Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion. J Cell Biochem 54:247-255.
67. Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF. 1995. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. J Cell Biochem 57:680-690.
68. Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW. 1990. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 7:491-502.
69. Yue TL, McKenna PJ, Ohlstein EH, Farach Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ, Stadel JM. 1994. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. Exp Cell Res 214:459-464.